Grade Post Therapy Clin (yc)
Notes
**Note 1:** Leave post therapy grade blank when
* No neoadjuvant therapy
* Clinical or pathological case only
* Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
* There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological
**Note 2:** Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.
* Per clarification from the CAP Cancer Committee based on the CAP Protocol, the following histologies must be assigned a G3 (code 3): Serous, clear cell, undifferentiated/de-differentiated carcinomas, carcinosarcomas, and mixed mesodermal tumors (Mullerian/MMMT) are *high risk (high grade)*
**Note 3:** If there are multiple tumors with different grades abstracted as one primary, code the highest grade.
**Note 4:** G3 includes anaplastic.
**Note 5:** Code 9 (unknown) when
* Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
* Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
* Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available
Metadata
SSDI
Code |
Description |
1 |
G1
FIGO Grade 1
G1: Well differentiated |
2 |
G2
FIGO Grade 2
G2: Moderately differentiated |
3 |
G3
FIGO Grade 3
G3: Poorly differentiated or undifferentiated |
9 |
Grade cannot be assessed (GX); Unknown |
<BLANK> |
See Note 1 |